Substrates for peptidase S01.029: kallikrein-related peptidase 14
Peptide and protein substrates that are thought to be physiologically relevant are indicated by P. Peptide and protein substrates that are thought to be pathologically relevant are indicated by D. Peptide and protein substrates that are not physiologically relevant are indicated by N. Synthetic substrates are indicated by S. Click on the symbol to show only physiological, non-physiological or synthetic substrates, or here to display all substrates. How cleavage sites have been identified are indicated by the following evidence codes: NT = N-terminal sequencing, MS = mass spectroscopy, MU = mutation, CS = consensus sequence, LC = liquid chromatography. To see all annotated cleavages for a protein substrate, click on the UniProt Accession.
| Substrate | Uniprot | Residue range | Cleavage Site | Cleavage type | Evidence | P4 | P3 | P2 | P1 | P1' | P2' | P3' | P4' | Reference | CutDB | MERNUM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Antileukoproteinase | P03973 | 26-132 | peptide-Arg45+Tyr-peptide | P | NT | Gln | Cys | Leu | Arg | Tyr | Lys | Lys | Pro | Borgoņo et al., 2007 | ||
| Antileukoproteinase | P03973 | 26-132 | peptide-Leu97+Met-peptide | P | NT | Gly | Gln | Cys | Leu | Met | Leu | Asn | Pro | Borgoņo et al., 2007 | ||
| Boc-Gln-Ala-Arg-NHMec | Boc-Gln-Ala-Arg+NHMec | S | Boc | Gln | Ala | Arg | AMC | - | - | - | Borgoņo et al., 2007 | |||||
| Boc-Gln-Arg-Arg-NHMec | Boc-Gln-Arg-Arg+NHMec | S | Boc | Gln | Arg | Arg | AMC | - | - | - | Borgoņo et al., 2007 | |||||
| Boc-Gln-Gly-Arg-NHMec | Boc-Gln-Gly-Arg+NHMec | S | Boc | Gln | Gly | Arg | AMC | - | - | - | Borgoņo et al., 2007 | |||||
| Boc-Leu-Gly-Arg-NHMec | Boc-Leu-Gly-Arg+NHMec | S | Boc | Leu | Gly | Arg | AMC | - | - | - | Borgoņo et al., 2007 | |||||
| Boc-Phe-Ser-Arg-NHMec | Boc-Phe-Ser-Arg+NHMec | S | Boc | Phe | Ser | Arg | AMC | - | - | - | Borgoņo et al., 2007 | |||||
| Boc-Val-Leu-Lys-NHMec | Boc-Val-Leu-Lys+NHMec | S | Boc | Val | Leu | Lys | AMC | - | - | - | Borgoņo et al., 2007 | |||||
| Boc-Val-Pro-Arg-NHMec | Boc-Val-Pro-Arg+NHMec | S | Boc | Val | Pro | Arg | AMC | - | - | - | Borgoņo et al., 2007 | |||||
| COL4A2 collagen, type IV, alpha 2 | P08572 | 184-1712 | peptide-Arg1077+Ala-peptide | P | Ala | Pro | Gly | Arg | Ala | Gly | Leu | Tyr | Borgoņo et al., 2007 | 20940 | ||
| COL4A2 collagen, type IV, alpha 2 | P08572 | 184-1712 | peptide-Arg1109+Gly-peptide | P | Lys | Gly | Glu | Arg | Gly | Thr | Thr | Gly | Borgoņo et al., 2007 | 20941 | ||
| Desmoglein-1 | Q02413 | 50-1049 | peptide-Tyr528+Ser-peptide | P | NT | Ser | Gln | Val | Tyr | Ser | Ser | Glu | Pro | Borgoņo et al., 2007 | ||
| FGA fibrinogen, alpha polypeptide isoform alpha preproprotein | P02671 | 20-866 | peptide-Arg38+Val-peptide | P | Arg | Gly | Pro | Arg | Val | Val | Glu | Arg | Borgoņo et al., 2007 | 20947 | ||
| FGA fibrinogen, alpha polypeptide isoform alpha preproprotein | P02671 | 20-866 | peptide-Arg510+His-peptide | P | Asp | Gly | Phe | Arg | His | Arg | His | Pro | Borgoņo et al., 2007 | 20948 | ||
| fibrinogen beta chain | P02675 | 31-491 | peptide-Arg44+Gly-peptide | P | Phe | Ser | Ala | Arg | Gly | His | Arg | Pro | Borgoņo et al., 2007 | 20949 | ||
| fibronectin | P02751 | 32-2386 | peptide-Arg290+Ala-peptide | P | Thr | Asp | Val | Arg | Ala | Ala | Val | Tyr | Borgoņo et al., 2007 | 20937 | ||
| fibronectin | P02751 | 32-2386 | peptide-Arg903+Ser-peptide | P | Gly | Thr | Pro | Arg | Ser | Asp | Thr | Val | Borgoņo et al., 2007 | 20942 | ||
| fibronectin | P02751 | 32-2386 | peptide-Arg2070+His-peptide | P | Thr | Pro | Ile | Arg | His | Arg | Pro | Arg | Borgoņo et al., 2007 | 20943 | ||
| H-Pro-Phe-Arg-NHMec | H-Pro-Phe-Arg+NHMec | S | - | Pro | Phe | Arg | AMC | - | - | - | Borgoņo et al., 2007 | |||||
| Kallikrein-1 precursor | P06870 | 20-27 | Ile-Gln-Ser-Arg24+Ile-Val-Gly | N | MS | Ile | Gln | Ser | Arg | Ile | Val | Gly | - | Emami & Diamandis, 2008 | ||
| Kallikrein-1 precursor | P06870 | 19-262 | peptide-Arg24+Ile-peptide | P | NT | Ile | Gln | Ser | Arg | Ile | Val | Gly | Gly | Emami & Diamandis, 2008 | ||
| Kallikrein-10 precursor | O43240 | 31-276 | peptide-Arg42+Leu-peptide | P | NT | Asn | Asp | Thr | Arg | Leu | Asp | Pro | Glu | Yoon et al., 2007 | ||
| Kallikrein-11 precursor | Q9UBX7 | 50-56 | Glu-Thr-Arg53+Ile-Ile-Lys | N | MS | - | Glu | Thr | Arg | Ile | Ile | Lys | - | Emami & Diamandis, 2008 | ||
| Kallikrein-11 precursor | Q9UBX7 | 51-282 | Glu-Thr-Arg53+Ile-peptide | P | NT | - | Glu | Thr | Arg | Ile | Ile | Lys | Gly | Emami & Diamandis, 2008 | ||
| Kallikrein-12 precursor | Q9UKR0 | 18-24 | Ala-Thr-Pro-Lys21+Ile-Phe-Asn | N | MS | Ala | Thr | Pro | Lys | Ile | Phe | Asn | - | Emami & Diamandis, 2008 | ||
| Kallikrein-12 precursor | Q9UKR0 | 18-248 | Ala-Thr-Pro-Lys21+Ile-peptide | P | NT | Ala | Thr | Pro | Lys | Ile | Phe | Asn | Gly | Yoon et al., 2007 | ||
| Kallikrein-13 precursor | Q9UKR3 | 17-277 | peptide-Lys25+Val-peptide | P | NT | Glu | Ser | Ser | Lys | Val | Leu | Asn | Thr | Yoon et al., 2007 | ||
| Kallikrein-14 precursor | Q9P0G3 | 35-267 | peptide-Lys40+Ile-peptide | P | NT | Asp | Glu | Asn | Lys | Ile | Ile | Gly | Gly | Yoon et al., 2007 | ||
| Kallikrein-15 precursor | Q9H2R5 | 17-256 | peptide-Lys21+Leu-peptide | P | NT | Asp | Gly | Asp | Lys | Leu | Leu | Glu | Gly | Yoon et al., 2007 | ||
| Kallikrein-2 precursor | P20151 | 20-27 | Ile-Gln-Ser-Arg24+Ile-Val-Gly | N | MS | Ile | Gln | Ser | Arg | Ile | Val | Gly | - | Emami & Diamandis, 2008 | ||
| Kallikrein-2 precursor | P20151 | 19-261 | peptide-Arg24+Ile-peptide | P | NT | Ile | Gln | Ser | Arg | Ile | Val | Gly | Gly | Yoon et al., 2007 | ||
| Kallikrein-5 | Q9Y337 | 62-69 | Ser-Ser-Ser-Arg66+Ile-Ile-Asn | N | MS | Ser | Ser | Ser | Arg | Ile | Ile | Asn | - | Emami & Diamandis, 2008 | ||
| Kallikrein-6 precursor | Q92876 | 17-244 | peptide-Lys21+Leu-peptide | P | NT | Glu | Gln | Asn | Lys | Leu | Val | His | Gly | Yoon et al., 2007 | ||
| Kallikrein-7 precursor | P49862 | 25-32 | Gln-Gly-Asp-Lys29+Ile-Ile-Asp | N | MS | Gln | Gly | Asp | Lys | Ile | Ile | Asp | - | Emami & Diamandis, 2008 | ||
| Kallikrein-9 precursor | Q9UKQ9 | 16-250 | peptide-Arg22+Ala-peptide | P | NT | Ala | Asp | Thr | Arg | Ala | Ile | Gly | Ala | Yoon et al., 2007 | ||
| kallikrein-related peptidase 14 | Q9P0G3 | 25-251 | peptide-Arg49+Ser-peptide | P | Thr | Cys | Thr | Arg | Ser | Ser | Gln | Pro | Borgoņo et al., 2007 | 20208 | ||
| kallikrein-related peptidase 14 | Q9P0G3 | 25-251 | peptide-Arg63+Arg-peptide | P | Ala | Gly | Pro | Arg | Arg | Arg | Phe | Leu | Borgoņo et al., 2007 | 20209 | ||
| kallikrein-related peptidase 14 | Q9P0G3 | 25-251 | peptide-Arg106+Thr-peptide | P | Tyr | Asn | Ser | Arg | Thr | His | Asp | Asn | Borgoņo et al., 2007 | 20210 | ||
| kallikrein-related peptidase 14 | Q9P0G3 | 25-251 | peptide-Arg141+Ala-peptide | P | Arg | Ile | Gly | Arg | Ala | Val | Arg | Pro | Borgoņo et al., 2007 | 20211 | ||
| kallikrein-related peptidase 14 | Q9P0G3 | 25-251 | peptide-Arg160+Val-peptide | P | Thr | Ser | Cys | Arg | Val | Ser | Gly | Trp | Borgoņo et al., 2007 | 20212 | ||
| kallikrein-related peptidase 14 | Q9P0G3 | 25-251 | peptide-Arg173+Tyr-peptide | P | Pro | Ile | Ala | Arg | Tyr | Pro | Ala | Ser | Borgoņo et al., 2007 | 20213 | ||
| kallikrein-related peptidase 14 | Q9P0G3 | 25-251 | peptide-Arg197+Thr-peptide | P | Ala | Tyr | Pro | Arg | Thr | Ile | Thr | Pro | Borgoņo et al., 2007 | 20214 | ||
| kallikrein-related peptidase 5 | Q9Y337 | 23-293 | peptide-Arg66+Ile-peptide | P | Ser | Ser | Ser | Arg | Ile | Ile | Asn | Gly | Brattsand et al., 2005 | 21057 | ||
| kininogen-1 | P01042 | 19-644 | peptide-Arg114+Ser-peptide | P | Val | Gly | Lys | Arg | Ser | Ser | Thr | Lys | Borgoņo et al., 2007 | 20946 | ||
| laminin subunit alpha-5 | O15230 | 36-3695 | peptide-Arg2421+Asp-peptide | P | Glu | Leu | Ser | Arg | Asp | Asn | Ala | Thr | Borgo¤o et al., 2007 | |||
| matrix metalloproteinase-14 | P50281 | 24-582 | peptide-Arg111+Tyr-peptide | P | NT | Arg | Arg | Lys | Arg | Tyr | Ala | Ile | Gln | Falkowski et al., 2020 | ||
| matrix metalloproteinase-15 | P51511 | 48-669 | peptide-Arg131+Tyr-peptide | P | NT | Arg | Arg | Lys | Arg | Tyr | Ala | Leu | Thr | Falkowski et al., 2020 | ||
| matrix metalloproteinase-15 | P51511 | 48-669 | peptide-Gly298+Ile-peptide | P | NT | Asp | Leu | Arg | Gly | Ile | Gln | Gln | Leu | Falkowski et al., 2020 | ||
| matrix metalloproteinase-16 | P51512 | 76-607 | peptide-Arg100+Cys-peptide | P | NT | Lys | Lys | Pro | Arg | Cys | Gly | Val | Pro | Falkowski et al., 2020 | ||
| matrix metalloproteinase-17 | Q9ULZ9 | 40-603 | peptide-Arg122+Arg-peptide | P | NT | Thr | Gln | Ala | Arg | Arg | Arg | Arg | Gln | Falkowski et al., 2020 | ||
| methoxysuccinyl-Val-Pro-Arg-NHMec | methoxysuccinyl-Val-Pro-Arg+NHMec | S | MSu | Val | Pro | Arg | AMC | - | - | - | Felber et al., 2006 | |||||
| plasminogen | P00747 | 20-810 | peptide-Lys96+Lys-peptide | P | Leu | Phe | Glu | Lys | Lys | Val | Tyr | Leu | Borgoņo et al., 2007 | 20944 | ||
| plasminogen | P00747 | 20-810 | peptide-Arg549+Lys-peptide | P | Thr | Asn | Pro | Arg | Lys | Leu | Tyr | Asp | Borgoņo et al., 2007 | 20945 | ||
| Prostate-specific antigen | P07288 | 25-261 | peptide-Tyr153+Ala-peptide | P | NT | Thr | Thr | Cys | Tyr | Ala | Ser | Gly | Trp | Emami & Diamandis, 2008 | ||
| Prostate-specific antigen | P07288 | 25-261 | peptide-Lys169+Lys-peptide | P | NT | Leu | Thr | Pro | Lys | Lys | Leu | Gln | Cys | Emami & Diamandis, 2008 | ||
| Prostate-specific antigen precursor | P07288 | 20-27 | Ile-Leu-Ser-Arg24+Ile-Val-Gly | N | MS | Ile | Leu | Ser | Arg | Ile | Val | Gly | - | Emami & Diamandis, 2008 | ||
| Prostate-specific antigen precursor | P07288 | 18-261 | peptide-Arg24+Ile-peptide | P | NT | Ile | Leu | Ser | Arg | Ile | Val | Gly | Gly | Emami & Diamandis, 2008 | ||
| proteinase-activated receptor 1 | P25116 | 27-425 | peptide-Arg41+Ser-peptide | P | MS | Leu | Asp | Pro | Arg | Ser | Phe | Leu | Leu | Oikonomopoulou et al., 2006 | 20599 | |
| proteinase-activated receptor 1 | P25116 | 27-425 | peptide-Phe43+Leu-peptide | P | MS | Pro | Arg | Ser | Phe | Leu | Leu | Arg | Asn | Oikonomopoulou et al., 2006 | 20600 | |
| proteinase-activated receptor 1 | P25116 | 27-425 | peptide-Arg46+Asn-peptide | P | MS | Phe | Leu | Leu | Arg | Asn | Pro | Asn | Asp | Oikonomopoulou et al., 2006 | 20601 | |
| proteinase-activated receptor 2 | P55085 | 26-397 | peptide-Arg36+Ser-peptide | P | MS | Ser | Lys | Gly | Arg | Ser | Leu | Ile | Gly | Oikonomopoulou et al., 2006 | 20611 | |
| proteinase-activated receptor 2 | P55085 | 26-397 | peptide-Lys51+Gly-peptide | P | MS | Val | Thr | Gly | Lys | Gly | Val | Thr | Val | Oikonomopoulou et al., 2006 | 20612 | |
| proteinase-activated receptor 2 | P55085 | 26-397 | peptide-Arg29+Ser-peptide | P | MS | Gly | Thr | Asn | Arg | Ser | Ser | Lys | Gly | Oikonomopoulou et al., 2006 | 20613 | |
| proteinase-activated receptor 2 | P55085 | 26-397 | peptide-Lys34+Val-peptide | P | MS | Leu | Ile | Gly | Lys | Val | Asp | Gly | Thr | Oikonomopoulou et al., 2006 | 20614 | |
| proteinase-activated receptor 2 | Q63645 | 26-397 | peptide-Arg36+Ser-peptide | P | MS | Ser | Lys | Gly | Arg | Ser | Leu | Ile | Gly | Oikonomopoulou et al., 2006 | ||
| proteinase-activated receptor 4 precursor | Q96RI0 | 18-385 | peptide-Tyr49+Pro-peptide | P | MS | Pro | Arg | Gly | Tyr | Pro | Gly | Gln | Val | Oikonomopoulou et al., 2006 | 20618 | |
| proteinase-activated receptor 4 precursor | Q96RI0 | 18-385 | peptide-Gly35+Asp-peptide | P | MS | Thr | Gly | Gly | Gly | Asp | Asp | Ser | Thr | Oikonomopoulou et al., 2006 | 20619 | |
| proteinase-activated receptor 4 precursor | Q96RI0 | 18-385 | peptide-Arg47+Gly-peptide | P | MS | Pro | Ala | Pro | Arg | Gly | Tyr | Pro | Gly | Oikonomopoulou et al., 2006 | 20620 | |
| proteinase-activated receptor 4 precursor | Q920E0 | 17-395 | peptide-Arg49+Gly-peptide | P | MS | Pro | Asn | Pro | Arg | Gly | Phe | Pro | Gly | Oikonomopoulou et al., 2006 | 20637 | |
| S-2222 | Bz-Ile-Glu-Gly-Arg+NHPhNO2 | S | Ile | Glu | Gly | Arg | NAN | - | - | - | Brattsand et al., 2005 | |||||
| S-2288 | D-Ile-Pro-Arg+NHPhNO2 | S | - | DIl | Pro | Arg | NAN | - | - | - | Brattsand et al., 2005 | |||||
| S-2302 | D-Pro-Phe-Arg+NHPhNO2 | S | - | DPr | Phe | Arg | NAN | - | - | - | Brattsand et al., 2005 | |||||
| S-2586 | MeO-Suc-Arg-Pro-Tyr+NHPhNO2 | S | Suc | Arg | Pro | Tyr | NAN | - | - | - | Brattsand et al., 2005 | |||||
| Somatotropin | P01241 | 27-217 | Peptide-Tyr169+Ser-Peptide | P | NT | Lys | Gln | Thr | Tyr | Ser | Lys | Phe | Asp | Komatsu et al., 2007 | ||
| Somatotropin | P01241 | 27-217 | Peptide-Arg90+Glu-Peptide | P | NT | Pro | Ser | Asn | Arg | Glu | Glu | Thr | Gln | Komatsu et al., 2007 | ||
| Tos-Gly-Pro-Arg-NHMec | Tos-Gly-Pro-Arg+NHMec | S | Tos | Gly | Pro | Arg | AMC | - | - | - | Borgoņo et al., 2007 | |||||
| vitronectin | P04004 | 20-478 | peptide-Arg64+Gly-peptide | P | Gln | Val | Thr | Arg | Gly | Asp | Val | Phe | Borgoņo et al., 2007 | 20951 | ||
| vitronectin | P04004 | 20-478 | peptide-Arg197+Asp-peptide | P | Lys | Leu | Ile | Arg | Asp | Val | Trp | Gly | Borgoņo et al., 2007 | 20952 | ||
| Z-Gly-Gly-Arg-NHMec | Z-Gly-Gly-Arg+NHMec | S | Z | Gly | Gly | Arg | AMC | - | - | - | Borgoņo et al., 2007 |
